Mkts

Harmony Biosciences Holdings, Inc.

NASDAQ: HRMY
$33.11+0.64 (+1.97%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
32.2733.38
52-week range
25.9043.49
Today
Open32.70
Previous close33.11
Volume—
Valuation
Market cap1.93B
P/E ratio10.64×
EPS (TTM)3.09
Income & risk
Dividend / yield—
Beta0.96
Avg volume956.6K
Discussion

HRMY News

Stories mentioning HRMY from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue215,387243,776239,455200,489184,733201,267186,038172,814
Cost of Goods Sold44,51268,54559,65038,15331,99454,40942,77832,144
Gross Profit170,875175,231179,805162,336152,739146,858143,260140,670
Operating Expenses
Research & Development69,38349,93354,96250,15934,54034,66625,38763,583
Sales General & Admin
Total Operating Expenses133,584136,674114,318114,15696,49491,13181,550119,314
Operating Income (Loss)37,29138,55765,48748,18056,24555,72761,71021,356
Interest Income
Interest Expense
Other Expense(127.00)(105.00)(106.00)(193.00)(276.00)160.00(124.00)37.00
Pretax Income39,68740,76067,49049,63757,17756,15562,17021,694
Tax Provision7,19918,27416,6259,86111,6176,68016,07710,103
Net Income (Loss)32,48822,48650,86539,77645,56049,47546,09311,591
Earnings Per Share (Basic)0.560.390.880.690.790.870.810.20
Earnings Per Share (Diluted)0.550.380.870.680.780.850.790.20
Weighted Average Shares Outstanding (Basic)57,81957,49257,55157,47057,31056,88556,87056,802
Weighted Average Shares Outstanding (Diluted)58,77658,54558,71858,42758,52557,87058,10457,542

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About HRMY

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is a stock listed on the Nasdaq Stock Market under the ticker symbol HRMY. It last traded at $33.11 (Nov 6, 2026, 4:00 PM ET), up 2.0% on the day. That gives Harmony Biosciences a market capitalisation of $1.9B and a price-to-earnings ratio of 10.6.

Over the past 52 weeks HRMY has traded between $25.90 and $43.49.

Revenue for the quarter ended Mar 31, 2026 was $215.4M; net income $32.5M. Revenue was up 16.6% from $184.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$215.4M$32.5M15.1%
Dec 31, 2025$243.8M$22.5M9.2%
Sep 30, 2025$239.5M$50.9M21.2%
Jun 30, 2025$200.5M$39.8M19.8%

From Harmony Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…